Vivos Therapeutics, Inc. (VVOS) — S-1/A Filings
All S-1/A filings from Vivos Therapeutics, Inc.. Browse 2 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (2)
-
Vivos Therapeutics Files S-1/A Update
— Jan 29, 2025 Risk: medium
Vivos Therapeutics, Inc. filed an S-1/A on January 29, 2025, detailing its financial performance. For the nine months ended September 30, 2024, the company repo -
Vivos Therapeutics, Inc. Files Amendment No. 1 to S-1 Registration Statement
— Apr 22, 2024 Risk: low
Vivos Therapeutics, Inc. (VVOS) filed a Amended IPO Registration (S-1/A) with the SEC on April 22, 2024. Vivos Therapeutics, Inc. filed an amendment (No. 1) to
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX